Naloxone Network

Nonprofit profile at a glance

EIN
333766668
IRS 990-EZ coverage
2025–2025
Forms available
Form 990-EZ 2025
Location
Bethesda, MD, USA
Rating confidence
Limited
Sector
Alcohol, Drug Abuse, Prevention Only

Reported finances

Revenue
$0
Expenses
$0
Assets
$0

Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

7 people listed

Executive titles in this filing

  • Payton McClarity-Jones (Co-Executive Director)
  • Sofia Pelayo (Co-Executive Director)

People named in this filing

  • Payton McClarity-Jones (Co-Executive Director)
  • Sofia Pelayo (Co-Executive Director)
  • Cameron Truman-Wyss (Baltimore Board Member)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

We are a harm reduction organization focused on minimizing the risk of opioid usage in Washington D.C. and Maryland. We do this by distributing the life-saving Naloxone drug along with fentanyl test-strips pamphlets and other educational materials for those seeking help with opioid addiction.

What it reported doing in 2025

Since our establishment as a 501c3 we have conducted over 50 community outreach events and distributed over 1000 doses of Narcan. Additionally we have fostered partnerships with 6 DC based-shelters and established a chapter in Baltimore Maryland.

Operating model

Revenue model
No positive adjusted resources. The filing reports no positive adjusted operating resources.
Distribution model
No current program activity. The filing reports no program spending for the current year.

The verdict

- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.

Rating breakdown

  • Financial Efficiency: NotEnoughData
  • Transparency & Controls: 41
  • Sustainability: NotEnoughData
  • Growth: NotEnoughData

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: Limited
  • Program expense ratio: Limited

Transparency & Controls

  • Consistency checks: 50%; rating input score 50; 0th percentile among comparable filings
  • Major donor itemization: Limited

Sustainability

  • Operating margin: Limited
  • Total-asset coverage ratio: Limited
  • Liabilities to assets ratio: Limited
  • Officer compensation ratio: Limited

Growth

  • Program expense growth: Limited
  • Revenue growth: Limited
  • Asset growth: Limited

Details

  • Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
  • Governance: Filed governance answers
  • Accomplishments: 1 filed program accomplishment
  • Leadership: top reported pay $0 · 7 people listed
  • Consistency: 4 of 5 current checks pass · 1 finding to review
  • Schedules: 2 filed schedules
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Moderate — Transparency & Controls: Series filing activity did not reconcile in the filed values.